Elutia Inc. (ELUT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Elutia Inc. (ELUT) has a cash flow conversion efficiency ratio of 0.066x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.89 Million) by net assets ($-43.92 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Elutia Inc. - Cash Flow Conversion Efficiency Trend (2018–2024)
This chart illustrates how Elutia Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Elutia Inc. total liabilities for a breakdown of total debt and financial obligations.
Elutia Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Elutia Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Arlitech Electronic
TWO:6432
|
0.004x |
|
Rank Progress S.A.
WAR:RNK
|
0.008x |
|
Quality & Reliability A.B.E.E
AT:QUAL
|
-0.032x |
|
M K Land Holdings Bhd
KLSE:8893
|
0.000x |
|
Snow Lake Resources Ltd
NASDAQ:LITM
|
0.000x |
|
Pan Global Resources Inc
V:PGZ
|
-0.312x |
|
Demisas Dokum Emaye Mamulleri Sanayi AS
IS:DMSAS
|
-0.026x |
|
Woosung Feed
KO:006980
|
0.128x |
Annual Cash Flow Conversion Efficiency for Elutia Inc. (2018–2024)
The table below shows the annual cash flow conversion efficiency of Elutia Inc. from 2018 to 2024. For the full company profile with market capitalisation and key ratios, see Elutia Inc. (ELUT) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-46.26 Million | $-22.66 Million | 0.490x | -13.12% |
| 2023-12-31 | $-38.60 Million | $-21.76 Million | 0.564x | -86.76% |
| 2022-12-31 | $-5.03 Million | $-21.43 Million | 4.259x | +472.79% |
| 2021-12-31 | $13.52 Million | $-15.45 Million | -1.142x | -74.64% |
| 2020-12-31 | $20.83 Million | $-13.63 Million | -0.654x | -598.95% |
| 2019-12-31 | $-55.11 Million | $-7.22 Million | 0.131x | +11.03% |
| 2018-12-31 | $-43.41 Million | $-5.12 Million | 0.118x | -- |
About Elutia Inc.
Elutia Inc., a commercial-stage company, develops and commercializes drug-eluting biologics products for neurostimulation and breast reconstruction in the United States. It operates in three segments: Device Protection, Women's Health, and Cardiovascular. The company offers EluPro, which is used to accommodate cardiac implantable electronic devices, such as pacemakers and internal defibrillators;… Read more